Company intelligence / Profile preview

Alpha Healthcare

New York, New York, United Statesalphahealthcarellc.com ↗

Ownership: Private
Development stage: Phase 2

Overview

The company’s lead programs are in Phase II clinical trials targeting bone and soft tissue repair using off-the-shelf allogeneic plasma-derived biomaterials. These products are designed to provide sustained local delivery of growth factors without requiring autologous blood/tissue harvesting, aiming to improve outcomes in orthopedic surgery, wound care, dental restoration, alopecia treatment, and cosmetic applications.

Therapeutic areas: OtherDermatology
Modalities: Allogeneic plasma-based biomaterials
Industry: Investors

Drug pipeline

1 asset

Bone Healing Accelerant

Phase 2

Indications: Tibia fracture, Foot and ankle fusion

Beyond the preview

Go deeper on Alpha Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha Healthcare.

Explore the full profile